140 related articles for article (PubMed ID: 38014450)
1. A rare cause of AA amyloidosis: Glomus tumor and treatment with anakinra-Case report and literature review.
Tastekin F; Kerim D; Sen S; Kabasakal Y
Int J Rheum Dis; 2024 Jan; 27(1):e14984. PubMed ID: 38014450
[TBL] [Abstract][Full Text] [Related]
2. Systemic Amyloidosis in a Patient With Familial Mediterranean Fever and Hodgkin Lymphoma: A Case Report.
Demir F; Bahadir A; Mungan S; Çobanoğlu Ü; Kalyoncu M
J Pediatr Hematol Oncol; 2020 Apr; 42(3):234-237. PubMed ID: 31094904
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma.
Nalcacioglu H; Ozkaya O; Genc G; Ayyildiz S; Kefeli M; Elli M; Aydin O; Ceyhan Bilgici M
Int J Rheum Dis; 2018 Feb; 21(2):552-559. PubMed ID: 29239128
[TBL] [Abstract][Full Text] [Related]
4. Amyloid A amyloidosis secondary to hyper IgD syndrome and response to IL-1 blockage therapy.
Kallianidis AF; Ray A; Goudkade D; de Fijter JW
Neth J Med; 2016 Jan; 74(1):43-6. PubMed ID: 26819362
[TBL] [Abstract][Full Text] [Related]
5. Anakinra induces complete remission of nephrotic syndrome in a patient with familial mediterranean fever and amyloidosis.
Sevillano ÁM; Hernandez E; Gonzalez E; Mateo I; Gutierrez E; Morales E; Praga M
Nefrologia; 2016; 36(1):63-6. PubMed ID: 26409501
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
[TBL] [Abstract][Full Text] [Related]
7. AA amyloidosis in inflammatory active malignant paraganglioma.
Ihne S; Kircher M; Papagianni A; Goetze O; Morbach C; Werner RA; Zeller D; Sommer C; Rosenwald A; Amann K; Linke RP; Lapa C; Einsele H; Geier A; Obici L; Palladini G; Knop S; Störk S
Amyloid; 2022 Jun; 29(2):137-138. PubMed ID: 35107388
[No Abstract] [Full Text] [Related]
8. Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome.
Aït-Abdesselam T; Lequerré T; Legallicier B; François A; Le Loët X; Vittecoq O
Joint Bone Spine; 2010 Dec; 77(6):616-7. PubMed ID: 20609610
[No Abstract] [Full Text] [Related]
9. Safety and efficacy of anti-interleukin-1 treatment in 40 patients, followed in a single centre, with AA amyloidosis secondary to familial Mediterranean fever.
Ugurlu S; Ergezen B; Egeli BH; Selvi O; Ozdogan H
Rheumatology (Oxford); 2020 Dec; 59(12):3892-3899. PubMed ID: 32556219
[TBL] [Abstract][Full Text] [Related]
10. Interventions for reducing inflammation in familial Mediterranean fever.
Yin X; Tian F; Wu B; Xu T
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD010893. PubMed ID: 35349164
[TBL] [Abstract][Full Text] [Related]
11. The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease.
Giat E; Ben-Zvi I; Lidar M; Livneh A
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409316
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
13. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
[TBL] [Abstract][Full Text] [Related]
14. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Kumon Y; Hirata S; Takaoka H
Clin Exp Rheumatol; 2014; 32(4):501-8. PubMed ID: 24959698
[TBL] [Abstract][Full Text] [Related]
15. AA amyloidosis as a complication of primary lymphedema.
Beloncle F; Sayegh J; Eymerit-Morin C; Duveau A; Augusto JF
Amyloid; 2014 Mar; 21(1):54-6. PubMed ID: 23964754
[TBL] [Abstract][Full Text] [Related]
16. Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.
Topaloglu R; Batu ED; Orhan D; Ozen S; Besbas N
Pediatr Nephrol; 2016 Apr; 31(4):633-40. PubMed ID: 26563115
[TBL] [Abstract][Full Text] [Related]
17. [AA amyloidosis complicating sarcoidosis: two cases and literature review].
Ben Abdelghani K; Mahfoudhi M; Hriz A; El Kossai I; Khefifi A; Turki S; Kheder A
Rev Med Interne; 2010 May; 31(5):369-71. PubMed ID: 20381218
[TBL] [Abstract][Full Text] [Related]
18. AA Amylodisis Associated with Jugular Paraganglioma as a Rare Cause of Chronic Diarrhea.
Olmos-Martínez JM; Mazorra R; Magadán C; Martín L; Crespo J
ACG Case Rep J; 2017; 4():e100. PubMed ID: 28848772
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
20. Systemic amyloidosis presenting as chronic diarrhea in a patient with ankylosing spondylitis.
McMahan ZH; Sailors JL; Toto R; Olsen NJ
J Clin Rheumatol; 2010 Jan; 16(1):22-5. PubMed ID: 20051751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
